World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
49
Citations
30610
World Ranking
2588
National Ranking
1269

Ed Reznik publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ed Reznik sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 128 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ed Reznik D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ed Reznik sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 49 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Ed Reznik is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple fields, primarily focusing on biochemistry, genetics, and molecular biology, as well as medicine. The scientist has contributed extensively to various subfields, including molecular biology, pulmonary and respiratory medicine, cancer research, oncology, and surgery.

Reznik's work concentrates on several key topics within the biomedical sciences. These include renal cell carcinoma treatment, cancer genomics and diagnostics, renal and related cancers, ferroptosis and cancer prognosis, bioinformatics and genomic networks, cancer immunotherapy and biomarkers, and computational drug discovery methods.

The scientist has published numerous papers, with notable recent works such as:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs, 2020, Cell
  • Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates, 2022, Journal of Clinical Oncology
  • Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA, 2021, Nature Metabolism
  • Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma, 2021, Clinical Cancer Research

Frequent publication venues for Reznik include:

  • The Journal of Urology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Zenodo (CERN European Organization for Nuclear Research)
  • Cancer Research
  • European Urology

Collaborations form a significant component of the scientist's work. Frequent co-authors include A. Ari Hakimi, Robert J. Motzer, Jonathan Coleman, Ritesh R. Kotecha, and Paul Russo. These collaborations reflect a diverse network within cancer research and urology.

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

    W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.

    André Kahles;Kjong-Van Lehmann;Nora C Toussaint;Matthias Hüser

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • The long tail of oncogenic drivers in prostate cancer

    Joshua Armenia;Stephanie A. M. Wankowicz;Stephanie A. M. Wankowicz;David Liu;David Liu;Jianjiong Gao

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith

  • Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

    Samra Turajlic;Samra Turajlic;Hang Xu;Kevin Litchfield;Andrew Rowan

  • An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

    A. Ari Hakimi;Ed Reznik;Chung Han Lee;Chad J. Creighton

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Mitochondrial DNA copy number variation across human cancers

    Ed Reznik;Martin Lee Miller;Yasin Şenbabaoğlu;Nadeem Riaz

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

    Fengju Chen;Yiqun Zhang;Yasin Şenbabaoğlu;Giovanni Ciriello

  • Pathway thermodynamics highlights kinetic obstacles in central metabolism

    Elad Noor;Arren Bar-Even;Avi I. Flamholz;Ed Reznik

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Bastien Nguyen;Christopher Fong;Anisha Luthra;Shaleigh A. Smith

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)

    Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith

Frequent Co-Authors

Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
Chris Sander
Chris Sander Harvard University
Nikolaus Schultz
Nikolaus Schultz Memorial Sloan Kettering Cancer Center
James J. Hsieh
James J. Hsieh Washington University in St. Louis
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Barry S. Taylor
Barry S. Taylor Memorial Sloan Kettering Cancer Center
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Timothy A. Chan
Timothy A. Chan Cleveland Clinic
Jianjiong Gao
Jianjiong Gao Memorial Sloan Kettering Cancer Center
Rameen Beroukhim
Rameen Beroukhim Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology can open the door to a range of healthcare careers, including advanced roles in nursing and research. If you’re considering a path that bridges biology with patient care, exploring online nursing degrees may be a practical next step.

For those interested in transitioning careers, there are accelerated programs tailored to various educational backgrounds. For example, the direct entry msn programs for non nurses online are designed for individuals without nursing experience but who want to quickly enter the field. Others who are already registered nurses may prefer the 6-month rn to bsn program to boost their credentials in a short span.

Those aiming for advanced roles, like nurse practitioner, should explore pathways outlining how to become nurse practitioner. Additionally, bridge programs, such as adn to np programs online, provide flexible options for registered nurses with an associate degree to accelerate their journey toward leadership roles.

With these online options, a foundation in Molecular Biology can be leveraged into diverse and fulfilling healthcare career pathways.

Best Scientists Citing Ed Reznik

Trending Scientists

Recently Published Articles